|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,389.40 INR | +0.44% |
|
-0.85% | -8.07% |
| 01:17am | India raises price cap on cancer drugs to tackle shortage | RE |
| 06-11 | Cipla's Goa, India Facility Receives VAI Status from US FDA | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CIPLA LIMITED | Generic Pharmaceuticals | +0.44% | -0.85% | -8.07% | -7.55% | +42.33% | 11.67B |  |  | |
- Stock Market
- Stocks
- CIPLA Stock
- Charts Cipla Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
